ASAlice M. Stokes

Alice M. Stokes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alice M. Stokes has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    An Overview of Information Instruction in Hospital Libraries in Spain

    by María Sobrido-Prieto, Alice M Stokes, Uxía Gutiérrez-Couto, Antonia María Fernández-Luque

    Introduction: Information instruction is essential to providing support for clinical care, teaching and research in hospitals. In the international literature, little has been published about this function of hospital libraries in Spain. This study examines the education activities of Spanish hospitals. Methods: A questionnaire about staff, education activities and institutional recognition was distributed via email to Spanish hospital libraries. The data was analysed in February 2023. Results: 84% of libraries provide education activities. The average number education staff is 1.3. Common instruction topics are database searching, citations, researcher identity and scientific journals (quality, impact and publication standards). 83% of libraries are part of the undergraduate medical curriculum, 67% are involved in graduate medical education, and 30% are part of the institutional research plan.


  • Open Access

    Biomarkers predictive of a response to extended endocrine therapy in breast cancer: a systematic review and meta-analysis

    by Kirsten M. Woolpert, Thomas P. Ahern, Timothy L. Lash, Donna L. O’mAlley, Alice M. Stokes, Deirdre P. Cronin-Fenton

    Purpose: Extension of adjuvant endocrine therapy beyond five years confers only modest survival benefit in breast cancer patients and carries risk of toxicities. This systematic review investigates the role of biomarker tests in predicting the clinical response to an extension of endocrine therapy. Methods: We searched Ovid MEDLINE, Ovid Embase, Global Index Medicus, and the Cochrane Central Register of Controlled Trials using an iterative approach to identify full-text articles related to breast cancer, endocrine therapy, and biomarkers. Results: Of the 1,217 unique reports identified, five studies were deemed eligible. Four investigated the Breast Cancer Index (BCI) assay in three distinct study populations. These studies consistently showed that BCI score was predictive of response to extended endocrine therapy among 1,946 combined patients, who were predominately non-Hispanic white and postmenopausal. Conclusions: Evidence in the setting of predictive tests for extended endocrine therapy is sparse. Most relevant studies investigated the use of BCI, but these study populations were largely restricted to a single age, race, and ethnicity group. Future studies should evaluate a variety of biomarkers in diverse populations. Without sufficient evidence, physicians and patients face a difficult decision in balancing the benefits and risks of endocrine therapy extension.